ITEMS IN AFP WITH KEYWORD:
Thyroid and Parathyroid Disorders
Treatment of patients with a minimally elevated thyrotropin (thyroid-stimulating hormone) level did not result in any improvement in symptoms. If patients present with a thyrotropin level between 4.6 and 10 mIU per L, repeat the test because the levels often normalize (this occurred in 60% of the patients initially referred for the study).
Learn about new research on the association between subclinical hyperthyroidism and the risk of cardiovascular disease and bone fractures.
Mar 1, 2017 Issue
Radioactive Iodine Therapy vs. Antithyroid Medications for Graves Disease [Cochrane for Clinicians]
Radioactive iodine therapy and antithyroid medications produce similar health-related quality-of-life outcomes in patients with Graves disease. Radioactive iodine therapy is an appropriate choice for patients who prefer definitive treatment.
Review the common causes, including Graves disease, toxic multinodular goiter, and toxic adenoma. Learn how to confirm the diagnosis and choose the most appropriate treatment option.
A 40-year-old woman presents for a routine well-woman examination. She is not pregnant, is in good health, reports no symptoms, and her physical examination is unremarkable. After seeing a health news segment on television, she asks if she should have her thyroid function checked.
Jun 1, 2015 Issue
Screening for Thyroid Dysfunction: Recommendation Statement [U.S. Preventive Services Task Force]
The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.
What are the effects of treatments for clinical (overt) hypothyroidism and subclinical hypothyroidism?
Learn how to differentiate between common types, and how each is treated.
Most patients receiving thyroid replacement therapy with less than 125 mcg of levothyroxine per day can wait two years before monitoring thyroid-stimulating hormone (TSH) levels if their results are normal. Fewer than one in 10 patients who take less than 125 mcg of levothyroxine per day with a norm...
Thyroid disease is the second most common endocrine disorder affecting women of reproductive age, and when untreated during pregnancy is associated with an increased risk of miscarriage, placental abruption, hypertensive disorders, and growth restriction. Current guidelines recommend targeted screen...